Apexian Pharmaceuticals

Biotechnology, Health Care, Pharmaceutical
Founded in 1/1/05
Indianapolis, Indiana, United States
http://www.apexianpharma.com/
For Profit

About Apexian Pharmaceuticals

Apex Therapeutics is an emerging clinical-stage biotechnology company founded on the scientific discoveries of Dr. Mark R. Kelley, whose groundbreaking work on APE1/Ref-1 redox protein signaling at the Indiana University School of Medicine has provided a unique insight into this novel biological target. It was founded in 2005 and headquartered in Indianapolis, Indiana.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: 9 active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 6875635 USD
  • Last Funding: 100000 USD (Venture - Series Unknown)
  • Funding Status:

Technology Stack

Apexian Pharmaceuticals actively uses 9 products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Pharmaceutical

Headquarters: Indianapolis, Indiana, United States